Tezepelumab for early-onset severe allergic asthma with persistent airflow limitation and small airway dysfunction: a treatable traits approach

Francesco Menzella, Claudio Sorino, Carlo Lombardi, Annamaria Bosi, Silvia Tonin, Lorenzo Corsi, Andrea Ballarin, Marcello Cottini

Article Type

Case Report & Review

Published

This article describes the clinical and functional evolution of a young patient with severe early-onset allergic asthma with impaired respiratory function treated with the anti-thymic stromal lymphopoietin biologic agent tezepelumab.

Read more

Nurses’ perceptions on the usability of the Hyrimoz® Sensoready® autoinjector device

Charlotte Both, Elena Bachinskaya, Laura Rose, Carol M Antequera, Jessica R Allegretti

Article Type

Original Research

Published

This survey of gastroenterology nurses in the USA was designed to assess nurses’ perceptions regarding the Hyrimoz Sensoready pen, and the degree to which unique features might influence patient education when compared with the reference medicine autoinjector device, the Humira pen.

Read more

Dupilumab reduces patient-reported cough and improves quality of life in patients with severe eosinophilic asthma with or without chronic rhinosinusitis with nasal polyps: a real-life prospective study

Carlo Lombardi, Alvise Berti, Francesco Menzella, Marcello Cottini

Article Type

Original Research

Published

The objective of this study was to assess the impact of dupilumab on chronic cough in patients with severe eosinophilic asthma and chronic rhinosinusitis with nasal polyps.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.